-
Sarepta slumps as trial failure deepens woes for drugmaker
04 Nov 2025 13:27 GMT
Audio By Carbonatix
(Reuters) -Sarepta Therapeutics’ shares plunged nearly 40% in premarket trading on Tuesday as failure of two of its approved drugs for a muscle wasting disorder in a key trial raised concerns about the strength of the company’s …
-
MIKE DAVIS: Foreign weight-loss drugmaker seeks fat profits by gobbling up American upstart
02 Nov 2025 13:45 GMT
… , such an acquisition requires federal scrutiny. First, due to antitrust concerns … this to avoid appropriate regulatory scrutiny in an unprecedented and potentially … drug prices, thankfully, many American pharmaceutical companies answered the call.
This deal …
-
GNQ Insilico Secures MindLab, an Award Winning Pharma Company, as a Client for its Drug Assessment Platform
30 Oct 2025 14:56 GMT
… developing controlled substances, where regulatory scrutiny and safety concerns demand unprecedented … response with unprecedented accuracy, enabling pharmaceutical companies to accelerate development timelines, reduce …
-
Partner in Kala Amb-based pharma firm arrested by NCB
04 Nov 2025 15:58 GMT
… Amb (Himachal Pradesh) — a pharmaceutical company already under scrutiny in multiple cases. Investigation …
-
Earnings: Hims & Hers stock surges as revenue bounces back
03 Nov 2025 22:08 GMT
… trading on Friday after the pharmaceutical company reported higher operating expenses, as … reserve. That model came under scrutiny, as the company's …
-
aTyr Pharma, Inc. (ATYR) Failed Drug Trial Spurs Securities Lawsuit; Class Period Significantly Enlarged -- Hagens Berman
03 Nov 2025 18:06 GMT
… Stakes of Clinical Trials: Why Pharma Companies Must Be Accurate and How … -dollar market opportunity. “We’re scrutinizing whether aTyr’s previous representations …
-
Pharmaceutical market poised for growth following Malaysia-US agreement
03 Nov 2025 12:32 GMT
… LUMPUR: The United States (US) pharmaceutical companies are likely to see increased … pharmaceutical companies.
"Drugmakers may face challenges such as reduced profit margins, increased scrutiny …
-
The Fine Print Behind TrumpRx’s ‘Discounts’
03 Nov 2025 09:03 GMT
… the nation’s largest pharmaceutical company.
Though the terms remain … landing page where leading drugmakers can sell directly to … today’s prescribing system, drugmakers effectively set the price. … continued work this year to scrutinize patent abuses. Still, …
-
Spotlight on soaring farm input costs
03 Nov 2025 06:57 GMT
… anticompetitive practices and led bipartisan scrutiny of agricultural mergers. Nearly a … model to abusive practices by pharmaceutical companies that distort intellectual property laws …
-
Former Trump NSA Warns Ireland Has Lost U.S. Confidence
02 Nov 2025 16:48 GMT
… in Washington is “under unprecedented scrutiny.”
“Ireland has long enjoyed a … driven by American tech and pharmaceutical companies operating in Ireland under favorable …